Showing results (1511-1520 of 1,662) with videos related to
Sort By:
Pageof 167
The Oncologist|August 18, 2009
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancerDennis S Chi, Rebecca Phaëton, Thomas J Miner, et al.Gynecologic Oncology|May 22, 2017
Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approachSusan K Lutgendorf, Eileen Shinn, Jeanne Carter, et al.The Journal of Physical Chemistry. B|July 18, 2009
Cationic nanoparticles induce nanoscale disruption in living cell plasma membranesJiumei Chen, Jessica A Hessler, Krishna Putchakayala, et al.Molecular and Cellular Neurosciences|November 24, 1999
Identification of a novel aspartic protease (Asp 2) as beta-secretaseI Hussain, D Powell, D R Howlett, et al.Neurobiology of Aging|March 28, 2009
Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicityGiuseppe D Ciccotosto, Deborah J Tew, Simon C Drew, et al.The Journal of Antimicrobial Chemotherapy|November 9, 2023
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control studyChin Fen Neoh, Sharon C A Chen, David C M Kong, et al.Bioorganic & Medicinal Chemistry Letters|March 14, 2000
2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S T Flynn, D M Hickey, et al.Gynecologic Oncology|January 22, 2020
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancerKaren A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2018
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research GroupTanya M Wildes, Ronald J Maggiore, William P Tew, et al.Gynecologic Oncology|February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trialAaron M Praiss, Qin Zhou, Alexia Iasonos, et al.Pageof 167